Synergistic Growth Inhibitory End product Of Herbal Extracts Against HCC And Lung Cancer Room
Khosit Pinmai from Thammasat University has investigated the mixture effects of P. T. bellerica extracts with conventional cytotoxic agents against human cancer cells. This study expose a synergistic effect of P. See also:
Data from the Department of Preclinical Science, Faculty of Medicine, Thammasat University, make evident that the flowering inhibitory activity of doxorubicin or cisplatin, as unmarried agents, may be modified in combination with emblic myrobalan or belleric myrobalan extracts and may be synergistically enhanced in some cases.
An article to be published on March 14, 2008, in the World Journal of Gastroenterology demonstrates the combination of effective phytochemicals with chemotherapeutic agents.
A study was conducted by Khosit Pinmai of Thammasat University, in which he evaluated the interaction of myrobalan pull out with chemotherapeutic pharmaceutical on cancer cell advance by isobologram and the grouping table of contents (CI) method of Chou-Talalay.
Several studies have shown that doxorubicin and cisplatin have harmful effects on health and can cutting edge to the evolution of primary and non-essential narcotic resistance in tumour cells, thereby limiting the clinical success of cancer chemotherapy.
Recent reports show that combination chemotherapy is a superior modality and that naturally occurring dietary supplements with known anti-cancer effects could be used in combination chemotherapy to reduce the systemic toxicity of chemotherapeutic agents.
When using synergistic drug set at corresponding dose levels, the calculation of the dose reduction index (DRI) at the IC50 demonstrated practicable reductions in doxorubicin concentrations representing the drug combinations, ranging from 1.64-fold (myrobalan + doxorubicin in A549) to 4.69-fold (myrobalan + doxorubicin in HEpG2).
The potion discount alike was contrastive and specific to each union and cell line.
These find support the speculation that combinations of plant extracts and chemotherapeutic agents allow a reduction in the dosage of the later (e.g.,
In the view of the authors, the apparatus of interaction between myrobalan extracts and chemotherapeutic drugs is unclear, and it is possible that multiple combine in the myrobalan extracts are involved.
Previously, phytochemical studies admit shown that myrobalan contains a variety of chemical components, including hydrolysable tannins (e.g.,
Further studies are needed to assess the underlying mechanism(s) and signal transduction pathways leading to growth inhibition induced beside single agents and combinations both in vitro and in vivo. Reference: Pinmai K, Chunlaratthanabhorn S, Ngamkitidechakul C, Soonthornchareon N, Hahnvajanawong C. Terrene J Gastroenterol 2008; 14(10): 1491-1497 http:
1007-9327 14 1491.asp Adapted from matter provided alongside World Annals of Gastroenterology, via EurekAlert!, AAAS.
Connected Stories Tea Pluck Assist Treat Damaged Pelt In Cancer Patients (Dec. 1, 2006) - Tea extracts commission as an competent treatment for patients who suffer from damaged skin following radiation treatment for cancer.
Researchers show that this energy partly be due to the anti-inflammatory. Enhancing Chemotherapy's Efficacy: New Agent Has Synergistic Effect With Standard Drugs (Apr. 16, 2007) - Integrating the use of drugs targeted to specific cancer proteins into current chemotherapy regimens to improve the efficacy of systemic treatment is an important clinical goal.
From http://sciencedaily.com/releases/2008/04/080430091758.htm